Daubin C,Parienti JJ,Fradin S.Procaleitonin levels and bacterial aetiology among COPD patients admitted to the ICU with severe pneumonia：a prospective cohort study [J].BMC Infectious Dis,2009,9(2)：157.
[6]
Sethi S.Molecular diagnosis of respiratory tract infection in acute exacerbations of chronic obstructive pulmonary disease [J].Clin Infect Dis,2011,52(Supple 4):290-295.
[7]
Bircan A,Gokirmak M,Kilic O,et al.C-reactive protein levels in patients with chronic obstructive pulmonary disease:role of infection [J].Med Princ Pract,2008,17:202-208.
[8]
Hurst JR,Donaldson GC,Perera WR,et al.Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease [J].American Journal of Respiratory and Critical Care Medicine, 2006,174： 867-874.
[9]
Lacoma A,Prat C,Andreo F,et al.Value of procaleitonin,C-reactive pmtein,and neopterin in exacerbations of chronic obstructive pulmonary disease [J].Int J Chron Obstruct Pulmon Dis,2011,6：157-169.
[10]
Daubin C, Parienti J,Vabret A,et al.Procalcitonin levels in acute exacerbation of COPD admitted in ICU: a prospective cohort study [J].BMC Infect Dis,2008,8：145.
[11]
Albrich WC,Dusemund F,Bucher B,et al.Effectiveness and safety of proealcitonin—guided antibiotic therapy in lower respiratory tract infections in“real life”:an international,muhicenter poststudy survey(ProREAL) [J].Arch Intern Med,2012,172:715-722.
[12]
Falsey AR,Becker KL,Swinburne AJ,et al.Utility of sernm procalcitonin values in patients with acute exacerbations of chronic obstructive pulmonary diseasea cau:tionary note [J].Int J Chron Obstruct Pulmon Dis,2012,7:127-135.
[13]
Bircan A,Gokirmak M,Kilic O,et al.C-reactive protein levels in patients with chronic obstructive pulmonary disease:role of infection [J].Med Princ Pract,2008,17:202-208.
